PERRONE, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.684
EU - Europa 2.122
AS - Asia 1.043
SA - Sud America 93
Continente sconosciuto - Info sul continente non disponibili 56
AF - Africa 27
OC - Oceania 12
Totale 6.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.622
PL - Polonia 784
RU - Federazione Russa 526
IT - Italia 364
SG - Singapore 332
CN - Cina 247
HK - Hong Kong 169
IE - Irlanda 99
VN - Vietnam 93
SE - Svezia 88
BR - Brasile 72
DE - Germania 71
KR - Corea 59
FR - Francia 39
GB - Regno Unito 38
CA - Canada 37
FI - Finlandia 35
JO - Giordania 27
IN - India 25
JP - Giappone 24
ES - Italia 16
CH - Svizzera 15
IQ - Iraq 13
ZA - Sudafrica 12
ID - Indonesia 11
NL - Olanda 11
AT - Austria 10
AU - Australia 10
BD - Bangladesh 10
MX - Messico 10
AR - Argentina 9
TR - Turchia 7
PK - Pakistan 6
UA - Ucraina 6
BE - Belgio 4
CI - Costa d'Avorio 4
DZ - Algeria 4
UZ - Uzbekistan 4
CL - Cile 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
BG - Bulgaria 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LT - Lituania 1
MQ - Martinica 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 5.981
Salva come PNG Salva come JPEG
Città #
Warsaw 777
Santa Clara 482
Ashburn 376
Singapore 223
Fairfield 154
Hong Kong 142
Chandler 129
San Jose 128
Dublin 99
Beijing 83
Houston 83
Cambridge 79
Seattle 79
Woodbridge 70
Wilmington 60
Seoul 58
Milan 56
Florence 51
The Dalles 51
Ann Arbor 44
Council Bluffs 43
Chicago 37
Altamura 36
Buffalo 36
Lawrence 32
New York 32
Los Angeles 29
Princeton 27
Rome 24
Bremen 23
Dallas 23
Ho Chi Minh City 21
Tokyo 21
Boston 20
Boardman 19
Lauterbourg 19
Munich 19
Shanghai 19
Hanoi 18
Helsinki 17
Medford 15
Mumbai 15
Paris 15
Bern 14
Hefei 14
Phoenix 14
Clifton 13
Kent 13
Johannesburg 11
Moscow 11
Melbourne 10
San Diego 10
Barcelona 9
Jacksonville 9
Jakarta 9
Toronto 9
Dong Ket 8
London 8
Naples 8
Norwich 8
Redondo Beach 8
Turin 8
Orem 7
São Paulo 7
Vienna 7
Venice 6
Cagliari 5
Da Nang 5
Guangzhou 5
Montreal 5
Norwalk 5
Stockholm 5
Abidjan 4
Amsterdam 4
Brasília 4
Brooklyn 4
Dearborn 4
Falls Church 4
Frankfurt am Main 4
Haiphong 4
Hải Dương 4
Lappeenranta 4
Mexico City 4
Newark 4
Tashkent 4
Tianjin 4
Baghdad 3
Brussels 3
Dhaka 3
Las Vegas 3
Latina 3
Manchester 3
Memphis 3
Mosul 3
Padua 3
Palermo 3
Perugia 3
San Francisco 3
Shenzhen 3
Sinalunga 3
Totale 4.133
Salva come PNG Salva come JPEG
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 363
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 352
Identificazione di MTHFR 1298A>C come marcatore predittivo di sopravvivenza in due coorti di pazienti con carcinoma colorettale (stadio II e III) trattati con chemioterapia adiuvante a base di fluoropirimidine con o senza oxaliplatino 338
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 330
Druggable Targets in Pancreatic Adenocarcinoma 325
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 290
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 277
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 262
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 256
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 249
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 247
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 236
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 220
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 215
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 210
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 209
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 206
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 189
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 185
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 181
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 172
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 158
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 157
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 142
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 139
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 129
Totale 6.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022159 0 0 0 6 3 17 4 21 12 14 26 56
2022/2023576 47 116 34 57 36 86 59 28 69 1 12 31
2023/2024248 4 21 30 10 11 27 27 72 6 7 15 18
2024/20251.399 56 128 89 236 396 190 19 90 64 41 46 44
2025/20261.695 191 179 79 126 232 77 233 93 100 151 46 188
2026/2027324 57 45 130 92 0 0 0 0 0 0 0 0
Totale 6.037